Alternatives to AIATELLA

Improve radiology reporting efficiency and report quality with Imorgon's reporting automation. As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports. Imorgon's unique advantages include: - guaranteed transfer of all measurements - usually DICOM SR - electronic worksheets for direct report population (eliminating dictation from notes) - worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc) - integration with Epic and other EHRs. - vendor-neutral Our dedicated support team ensures uninterrupted workflow. Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.

Zebra's Imaging Analytics Engine processes imaging scans from multiple modalities and conducts automatic analyses of various clinical findings, ensuring efficiency and seamless integration with the radiology workflow. Healthcare providers rely on Zebra-Med to notify them about patients who are at elevated risk for cardiovascular, pulmonary, skeletal, and other health issues. This system enhances preventative care initiatives, supports accurate risk adjustments, and aids in meeting quality benchmarks like MACRA. By utilizing Zebra-Med, healthcare professionals can concentrate their efforts on the most vulnerable patients at critical moments, ultimately leading to reduced expenses and enhanced patient care outcomes. Consequently, this innovative approach not only improves the quality of care provided but also optimizes resource allocation across the healthcare system.

ProtonPACS, a picture archiving solution, manages image storage, distribution, and optimizes workflow throughout the organization. It offers front and back-end patient management solutions that reduce manual and/or duplicate patient information entry. Integration of HL7 to information systems (EHRs, RISes, etc.) The platform includes this feature. ProtonPACS includes Intelerad's Inteleviewer. This diagnostic viewer gives radiologists and other healthcare professionals the tools to optimize images and change layouts, measure critical points, perform image reconstructions, and create key images. Radiologists can use the integrated speech recognition engine and worklist to create reports for referring doctors. Both reports and images are accessible via any web-enabled device from the system's portal. ProtonPACS uses a secure hybrid model that combines on-premise hardware and cloud hosting.

Altris AI is an advanced, cloud-based clinical decision support system powered by artificial intelligence, specifically tailored to aid eye care professionals in interpreting OCT scans and making informed decisions. The platform streamlines the identification of pathological OCT scans while recognizing over 70 retina-related pathologies and biomarkers, which include some that are quite uncommon. Features of the system encompass severity detection, analysis of retina layer thickness, layer segmentation, and both automatic and manual measurement capabilities. It is designed to work seamlessly with all OCT devices and accommodates various data formats like DICOM, JPEG, and PNG. Furthermore, Altris AI has received FDA clearance, CE certification, and is compliant with GDPR and HIPAA regulations, thereby upholding rigorous standards for data security and patient confidentiality. By integrating this innovative tool into their practices, eye care professionals can significantly enhance patient triage, improve diagnostic precision, and more effectively track the progression of diseases over time. As a result, the adoption of Altris AI not only streamlines workflows but also elevates the overall quality of patient care in eye health.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Elevate the effectiveness of value-based care through the OMS Trace Analytics® cloud platform, which specializes in the analysis and reporting of essential cardiovascular metrics. As reimbursement increasingly hinges on value, it's important to note that in the 2018 performance year, 60% of Medicare reimbursements were associated with quality metrics under the Quality Payment Program. This emphasizes the growing necessity for a precise data-driven and evidence-based quality reporting solution aimed at measuring, targeting, and enhancing your quality initiatives. The OMS Trace Analytics® cloud platform is expertly crafted to provide profound clinical insights into cardiovascular conditions, featuring dedicated dashboards that focus on key cardiovascular issues such as Hypertension, Dyslipidemia, Atrial Fibrillation, Heart Failure, Coronary Artery Disease, and Peripheral Artery Disease. With the integration of such advanced analytics, healthcare providers can better navigate the complexities of value-based care while actively improving patient outcomes.

Healthcare providers can offer optimal treatment when equipped with advanced and user-friendly technology. Enhance your efficiency with our top-tier cardiovascular imaging solution. Drawing from over ten years of experience in streamlining workflows, we focus on improving your practice. Effortlessly identify wall motion abnormalities with our system. Key metrics such as stroke volume, ejection fraction, as well as end-diastolic and end-systolic volumes and masses are automatically displayed. Evaluate intricate cardiovascular structures through both 2D and 3D visualization options, along with a variety of measurement tools. Our solution delivers objective, automated quantitative analysis of myocardial blood flow, achieving expert-level precision without user bias. Additionally, it allows for the visualization and quantification of enhanced fibrosis distribution. In the DICOM images, colored lines indicate corresponding areas in the ADAS 3D image for each slice, facilitating a comprehensive understanding of the patient's condition. By integrating these features, we aim to empower healthcare professionals with the insights needed for informed decision-making.

Effortlessly identify the suitable landing zone for the treatment of abdominal aneurysms (EVAR), thoracic aneurysms (TEVAR), or the insertion of fenestrated stents (FEVAR). All necessary metrics, including diameter, clock position, volume, and length, can be accurately acquired through automatically detected centerlines or 3D double oblique imaging. Furthermore, integrated manufacturer stent order sheets can create PDF files, simplifying the process of ordering specific stents via email. Our ongoing mission is to enhance the quality and efficiency of cardiovascular image analysis, which in turn optimizes patient treatment outcomes. We strive to align our product offerings with the most recent advancements in the cardiovascular sector. By doing so, we ensure that our customers receive the best software solutions at the most opportune moments. Recognizing the significance of proper training and support, we are committed to making sure all users are proficient and comfortable with their analysis. To meet diverse needs, we provide customizable training options that adapt to individual requirements, fostering a supportive learning environment for all users.

Riverain Technologies has developed ClearRead Xray, a suite of five applications that have received FDA clearance, aimed at improving the speed and precision of interpreting chest X-rays within healthcare settings, all without the need for extra equipment, procedures, or exposure to radiation. This innovative platform utilizes specialized suppression technology to create a clear view of the chest, which significantly aids in the swift and precise identification of cardiothoracic conditions. Among its standout features are the generation of bone-suppressed images that enhance visualization, the ability to spot potential lung cancer nodules, a decrease in the time required to read portable X-rays, automatic comparisons with previous examinations to emphasize changes, and compatibility across various imaging devices and protocols throughout the enterprise. Additionally, the ClearRead Xray Bone Suppress feature notably enhances soft tissue visibility by minimizing the presence of bone structures in digital images, thereby assisting radiologists in uncovering nodules that may have previously gone unnoticed. This comprehensive approach not only boosts diagnostic capabilities but also streamlines workflow in busy medical environments.

The INFINITT Cardiology Suite serves as a comprehensive platform that consolidates all cardiovascular information into a single solution, enhancing the management, analysis, reporting, and submission of images to various data registries. Furthermore, it has received certification from the American College of Cardiology (ACC), confirming that version 1.0.8.1 of the INFINITT Cardiology Suite complies with the NCDR standards for the CathPCI Registry® version 5. This suite functions as an online PACS and reporting tool tailored for cardiology and vascular imaging, as well as EKG and nuclear medicine applications. It can operate independently or integrate seamlessly with INFINITT PACS, thereby unifying data for electronic health records (EHR). Users can customize report templates that are compatible with Dragon Dictation, allowing for flexibility and efficiency. Additionally, the suite offers both basic and advanced measurement tools for echocardiography, non-invasive vascular imaging, EKG, nuclear medicine, and cardiac catheterization studies. It provides sophisticated report generation capabilities, including the automatic population of measurements and interpretations, which significantly reduces transcription expenses and enhances workflow efficiency. This integration leads to improved patient outcomes through timely access to comprehensive data.

InsiteOne serves as a holistic platform for enterprise imaging, integrating medical imaging, data oversight, and diagnostic processes into a single, cloud-capable solution. The platform features a vendor-independent archive designed to hold imaging and clinical information across various departments such as radiology, cardiology, and pathology, while adhering to standards like DICOM, FHIR, and IHE to ensure smooth interoperability. It can be utilized in various deployment models, including on-premises, public or private cloud, or hybrid environments, facilitating centralized data storage, automated lifecycle management, enriched metadata, and robust encrypted data protection along with geographically diverse disaster recovery options, thereby safeguarding an immense volume of clinical images and patient information. In addition to its storage capabilities, InsiteOne enhances enterprise imaging accessibility by allowing clinicians to view diagnostic images through a zero-footprint, browser-based viewer compatible with desktops, tablets, and mobile devices, enabling them to conduct measurements, engage in 3D volume rendering, and perform detailed reviews without the necessity of specialized workstations. This comprehensive approach not only simplifies the imaging process but also significantly improves the efficiency of clinical workflows.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Medis Suite XA serves as our comprehensive solution for X-Ray angiography, built upon over three decades of expertise in cardiovascular image analysis. This all-inclusive package features an array of modules, including a user-friendly viewer and various analyses dedicated to coronary and vascular assessments, enabling detailed anatomical evaluations of arteries. It also encompasses analyses for both left and right ventricles along with integrated reporting capabilities. Among its offerings are advanced analyses for coronary and peripheral vessels (QCA and QVA) as well as left and right ventriculograms (QLV and QRV). A standout feature is the innovative QFR® analysis, which evaluates the functional significance of lesions without requiring adenosine or a pressure wire. Moreover, the suite allows for seamless integration within the healthcare IT infrastructure, ensuring effortless connectivity with the DICOM network, thus enhancing workflow efficiency and patient care. Ultimately, Medis Suite XA represents a significant advancement in the field of cardiovascular imaging.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

PowerScribe One represents an advanced radiology reporting solution that utilizes artificial intelligence to enhance both diagnostic precision and workflow productivity. By leveraging Microsoft Cloud for Healthcare, this platform automates key elements of the radiology reporting process, such as creating initial impressions and providing immediate clinical insights. Its innovative features, which include Smart Impression and AI-driven findings, empower radiologists to generate comprehensive reports more swiftly and with reduced mistakes. Additionally, PowerScribe One facilitates smooth connectivity with electronic medical records (EMR) and incorporates cloud-based speech recognition technology, leading to more accurate documentation. This combination not only streamlines the reporting process but also significantly contributes to better patient care and outcomes. Ultimately, the integration of these technologies positions PowerScribe One as a vital tool for modern radiology practices.

Fluency for Imaging is a speech-driven radiology reporting solution designed to improve efficiency, accuracy, and workflow automation in medical imaging environments. Developed by Jacobian, the platform integrates advanced speech recognition technology with AI-assisted reporting tools to support radiologists in generating high-quality diagnostic reports. Radiologists can dictate findings naturally while the system automatically structures the information into standardized report formats. Fluency for Imaging also supports the transfer of measurement data and AI findings directly from PACS systems into the report, eliminating manual data entry and reducing the risk of transcription errors. Built-in guideline support provides classification and scoring assistance using frameworks such as BI-RADS, PI-RADS, and TNM. The platform incorporates intelligent nudging and real-time feedback to help maintain report accuracy and compliance with clinical standards. Fluency for Imaging also supports ontology-based coding using standards such as RadLex, SNOMED CT, and ICD-10, enabling structured reporting and improved interoperability with hospital systems. With multimedia reporting capabilities, radiologists can include annotated images, tables, and visual elements directly within reports to enhance clarity and communication. By combining AI automation, structured reporting, and seamless system integration, Fluency for Imaging helps healthcare organizations streamline radiology workflows and improve diagnostic reporting quality.

Version 8.0 of PDQuest 2-D analysis software provides a robust and adaptable platform for conducting 2-D gel electrophoresis analysis. Users can opt for PDQuest Basic for straightforward 2-D gel evaluations or PDQuest Advanced to access the most cutting-edge features designed for in-depth expression proteomics research. Regardless of the version selected, the advanced analytical tools effectively highlight subtle variations across different 2-D gels. The software employs powerful auto-matching algorithms that ensure quick and precise gel matching with minimal manual effort. Furthermore, PDQuest's versatile annotation capabilities make it an invaluable asset for creating a centralized database, enabling a wide array of characterization data to be associated with each spot on a master gel image. Sharing and reviewing information related to identified proteins is made simple and efficient. Additionally, the software offers adaptable spot cutting configurations that enhance accuracy, throughput, and flexibility in protein identification trials, making it an essential tool for researchers in the field.

Join AI is transforming the healthcare landscape with AI-powered tools designed to assist in radiology and endoscopy diagnostics. The platform offers AI-driven solutions for chest imaging, breast imaging, stroke detection, and gastrointestinal endoscopy, enabling clinicians to detect conditions like lung diseases, breast tumors, and gastrointestinal infections more efficiently. Join AI’s algorithms provide deeper insights, aiding in early diagnosis and faster decision-making, which are crucial for improving patient care and treatment outcomes. With seamless integration into existing workflows, the platform empowers healthcare professionals to make more confident decisions.

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

Our innovative AI solutions are crafted to enhance the capabilities of healthcare professionals at critical stages of the medical process. Whether it's during preventive screenings, early diagnosis, emergency interventions, managing institutional disease outbreaks, or ensuring treatment compliance, we facilitate a smooth optimization of workflows throughout the entire care spectrum. By partnering with esteemed healthcare authorities and leveraging vast amounts of data to inform our algorithms, we ensure that our AI meets the highest global regulatory requirements. Supported by extensive research in data science, our offerings are designed to predict healthcare needs, especially in challenging situations. Our AI solutions are primed for immediate use, adaptable to various settings and situations as necessary. They seamlessly integrate with your existing technology framework and can be customized to work with your preferred devices. We provide straightforward deployment and scaling options while guaranteeing top-tier data security that complies with industry standards. Additionally, our dedicated team is committed to guiding you through every phase of your AI implementation journey, ensuring you feel confident and supported. With our solutions, you can transform your healthcare delivery and improve patient outcomes significantly.

MiNNOVAA is a company specializing in medical information technology, particularly in the realms of medical imaging software and the exchange of medical images. With the guiding principle of "medical imaging innovation," we stand out for our nimbleness and the state-of-the-art technology we utilize in crafting our solutions. Our main areas of concentration are the development of medical image viewers, enhancement of radiology workflows, and the incorporation of artificial intelligence in diagnostic reporting. Our energetic team comprises around 20 skilled programmers and product managers, alongside professionals in marketing, sales, technical support, call center operations, and administration, all dedicated to driving a meaningful transformation in the field of medical imaging and enhancing individual healthcare experiences. We offer a comprehensive clinical imaging IT solution tailored for mid-sized hospitals and imaging clinics, featuring a wide array of functionalities such as on-premise core PACS software, a DICOM web viewer, multi-platform imaging workstation software, seamless integration with EHR/EMR/HIS systems, and an efficient workflow engine/RIS. Ultimately, our commitment to innovation and comprehensive solutions aims to redefine how medical imaging is approached and utilized within healthcare settings.

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.

Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.

OMS Diagnostics® offers a comprehensive cardiovascular diagnostic reporting platform designed for both physicians and technologists, enabling them to create, interpret, and report on a diverse range of diagnostic methods, including echocardiograms, myocardial perfusion imaging, PET scans, Holter monitoring, EKGs, and ambulatory cardiac telemetry. Additionally, the OMS Diagnostics® module for lower extremity venous reflux ultrasound equips users with the tools necessary to document cases of lower extremity peripheral reflux disease effectively. This module facilitates the identification and documentation of abnormal structures, stenosis, and various anatomical irregularities. The resulting lower extremity venous ultrasound reports are both detailed and impressive, featuring tailored statements that contribute to the overall narrative. Notably, information regarding the presence or absence of thrombus and insufficiency is clearly presented in an organized table, enhancing readability. Furthermore, the illustrations depict the completed vessels as the data is entered, providing a visual representation of the findings. Preliminary reports are generated instantly, allowing for prompt review and signing by healthcare professionals, thus streamlining the diagnostic process. This efficient workflow ultimately supports better patient care through timely and accurate reporting.

CARPL.ai serves as a vendor-agnostic artificial intelligence platform designed to empower radiologists in accessing, evaluating, and incorporating a wide range of radiology AI solutions into their everyday clinical workflows. This innovative platform boasts an extensive collection of over 140 AI applications from more than 60 different vendors, thereby aiding in the discovery, exploration, validation, and implementation of various AI tools. By providing a unified technical integration along with a user-friendly interface, CARPL.ai simplifies the process of adopting multiple AI systems effectively. The platform is versatile, accommodating both cloud-based and on-premise deployments to suit diverse clinical settings. Additionally, it features a universal AI viewer that allows for the viewing, editing, and annotating of AI-generated outputs while also providing pre-deployment validation and ongoing post-deployment monitoring to maintain the systems' performance over time. With seamless integration into existing Picture Archiving and Communication Systems (PACS), CARPL.ai enhances patient care, minimizes turnaround times, and boosts diagnostic accuracy, ultimately transforming the radiology landscape for better healthcare outcomes. Furthermore, its commitment to adaptability and ease of use makes it a valuable asset for radiologists looking to leverage AI technology in their practices.

Innovative AI solutions that smoothly integrate with your PACS and radiology processes empower radiologists to streamline their workflows and enhance patient care. As the demand for medical imaging continues to rise, radiologists are often overwhelmed by the sheer volume of data, which can lead to increased reporting errors, elevated workloads, and disorganized processes. By automating repetitive tasks and standard measurements, AI technology assists radiologists in producing high-quality, evidence-based reports. This enhancement not only aids referring doctors and physicians in making well-informed decisions but also fosters a more intuitive workflow, ultimately benefiting patient care. Furthermore, these systems excel at identifying, characterizing, and classifying critical elements with pinpoint accuracy while maintaining the highest image quality and ensuring rapid loading times. Additionally, the inclusion of intelligent suggestions during report template searches, along with the ability to use pre-filled or customizable report templates, greatly improves standardized clinical communication and efficiency in the reporting process. By adopting such advanced tools, radiologists can focus more on patient interactions and less on administrative burdens.

NeuroQ stands out as a premier software for brain imaging analysis, delivering a robust diagnostic resource applicable across various modalities and clinical scenarios. This comprehensive tool supports an array of imaging techniques, including FDG, Amyloid, SPECT, DaTscan, and Epilepsy, thereby enhancing diagnostic precision in differentiating between various conditions. As one of the most prevalent quantitative instruments utilized in the differential diagnosis of dementia, NeuroQ transcends simple visual evaluations by offering crucial, objective diagnostic insights. It efficiently assesses metabolic levels across over 240 predefined brain regions, contrasting them with a normative database to quantify the extent of abnormalities and their statistical significance. Designed to assist in the evaluation of human brain scans, NeuroQ meticulously quantifies mean pixel values within standardized areas of interest and allows for detailed comparisons with other brain images, ultimately contributing to better patient outcomes. This innovative software is essential for clinicians seeking reliable data to inform their diagnostic processes and treatment decisions.

Realize Medical's Elucis is an FDA-approved extended reality platform that simplifies the segmentation of images, promotes collaboration among remote teams, and allows for procedural planning in a virtual reality space. Elucis is capable of handling an unlimited number of 3D and 4D CT and MR images, ensuring thorough project integration. It boasts cutting-edge image processing features, including both manual and automatic registration, as well as the display of images in 2D, 3D, and 4D formats. The platform’s segmentation tools are engineered for efficiency and user-friendliness, enabling precise measurement, cutting, and planning tasks directly in a virtual environment. Additionally, Elucis includes advanced 4D modeling capabilities that permit intricate segmentation of cardiac structures in mere minutes, regardless of the phase. Users have the flexibility to import 3D structure files from external sources and can easily export their work with a single click. Furthermore, the platform enhances teamwork by allowing multiple users to connect seamlessly with local or remote colleagues throughout the entire workflow, making it a versatile tool for medical professionals. This feature not only streamlines communication but also ensures that all stakeholders can contribute effectively to the project.

Our innovative AI solution empowers healthcare practitioners to conduct high-quality ultrasound examinations anytime and anywhere, irrespective of their experience level with ultrasound technology. While ultrasound serves as a reliable and effective diagnostic instrument, mastering its use can be challenging, requiring extensive specialized training and often resulting in variable image quality. The examination process demands precise hand-eye coordination and can be visually unintuitive, complicating the learning curve. Moreover, conventional ultrasound software fails to provide guidance on how to maneuver the ultrasound transducer effectively or offer immediate feedback regarding the clarity of the images obtained. This can lead to subpar imaging, which in turn results in overlooked diagnoses, unnecessary repeat exams, and inconsistent interpretations of the results. Consequently, the full potential and advantages of ultrasound technology have not been completely harnessed. With the advent of our AI-driven technology, any healthcare provider can now effortlessly capture high-quality diagnostic ultrasound images, as the AI assists them throughout each phase of the scanning procedure, ensuring accuracy and efficiency. This advancement not only enhances the diagnostic capabilities of healthcare providers but also promotes better patient outcomes through timely and accurate assessments.

Clario’s Imaging Platform offers a secure and efficient solution that ensures precise results for clinical trials of varying complexities. We utilize our in-house medical specialists and proprietary imaging technologies to tailor your workflow and analysis according to your specific requirements. By employing our dedicated engineering teams, you can avoid the additional costs and time delays commonly associated with third-party systems. As the leading Imaging Core Lab globally, Clario boasts a team of over 30 physicians and 35 scientists who specialize in medical imaging. Our extensive experience in evaluating and analyzing medical images has significantly shaped the evolution of our proprietary imaging solutions. The SMART Submit application from Clario integrates this wealth of expertise at every stage, beginning with the initial screening of medical images for errors at the hospital and continuing through to the final interpretation of the images. In doing so, we ensure that every aspect of the imaging process meets the highest standards of quality and accuracy.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

Hospitals and imaging facilities are overwhelmed by the influx of discs from various external sources. The process of manually importing this data proves to be both labor-intensive and expensive. However, with the implementation of the Automated Disc Importer, these organizations can efficiently transfer large quantities of discs into either temporary cloud storage or local systems without requiring human assistance. After the discs are processed, users are able to validate the data before it is officially archived. Additionally, this system enhances security by capturing an image of each disc label during the reading process, which aids in maintaining a comprehensive audit trail. These photographs not only document the imports but also specify the origin of each disc. By leveraging the Automated Disc Importer, medical images and reports from DICOM discs are effectively processed, significantly minimizing the time previously dedicated to manual data entry, and improving overall workflow efficiency. This innovation represents a substantial advancement in the management of medical imaging data.

Caas MR 4D Flow is expertly crafted to efficiently extract pertinent data from 3D phase-contrast MR images with minimal effort. Utilizing these advanced images, it provides two innovative 4D Flow modules that facilitate comprehensive flow analysis, which is instrumental in the assessment and interpretation of cardiovascular MR images, as well as in strategizing the timing and nature of interventions. One of these modules focuses on evaluating blood vessels, ranging from major arteries like the aorta to smaller vessels such as those found in the kidneys, while the other specializes in assessing heart valves concerning regurgitation fraction. Among the significant outputs are the visualization of aortic blood flow presented as streamlines, pathlines, and color-coded vectors; detailed mapping of wall shear stress alongside localized wall shear stress values; measurement of pressure differences across specific segments; and the visualization and quantification of regurgitant fractions for all four heart valves, in addition to conducting 2D flow phase-contrast analyses. This comprehensive approach not only enhances understanding but also significantly aids clinicians in making informed decisions regarding patient care.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

SARC MedIQ provides a comprehensive range of AI-driven medical imaging solutions aimed at enhancing and modernizing the entire diagnostic process, beginning with image acquisition and extending to reporting and distribution. Among its offerings is SARC PACSFlow, an AI-enhanced streaming PACS that facilitates immediate and secure access to high-quality diagnostic images, eliminating the need for outdated methods like CDs or manual uploads, thereby allowing healthcare professionals to review and manage studies from virtually anywhere. Additionally, SARC ShareSecure replaces traditional physical media with a secure cloud-based image sharing system that features encrypted access, integrated viewing capabilities, and customizable user permissions for rapid and compliant data sharing. SARC AiReports automates the reporting process by extracting measurements, implementing clinical guidelines, and filling in structured templates, which greatly minimizes manual data entry while enhancing accuracy and reducing turnaround times. Furthermore, SARC AiDictate utilizes AI to transform spoken words into complete medical reports, streamlining documentation processes and ensuring efficiency in clinical settings. Overall, these innovative tools not only support healthcare providers in their daily tasks but also aim to improve patient outcomes through enhanced diagnostic capabilities.

Over the past twenty years, collaboration with innovative thinkers has enabled the identification, understanding, and reduction of errors from biopsy to data, resulting in significant advancements in tissue data mining tools, precision, workflow, and automation. Explore the realm of image analysis and tissue mining in both multi and highplexed images, where you can extract clinically significant patterns that provide insights into diseases, transforming your research tissue images into valuable knowledge. Discover the capabilities of CE-IVD APPs and workflows in image analysis, and redefine the approach to standardization through AI-powered pathology solutions that enhance diagnostic decision-making. The app center serves as your entry point to an extensive library filled with AI-driven applications, including those designed to adapt to your specific requirements. Additionally, you can peruse our collection of publications, guides, webinars, and posters to deepen your understanding of digital pathology and see how our software continually supports our clients in their research efforts. Embrace the future of pathology by leveraging these innovative tools and resources to elevate your work and contribute to advancing medical science.

Arterys is an innovative medical imaging AI platform that seamlessly integrates advanced AI clinical applications into your existing PACS or EHR workflows, making it an intuitive extension of your current practices. Our goal is to bring AI into the forefront by enhancing physician experiences, improving diagnostic accuracy and treatment efficacy, optimizing financial outcomes, and providing significant benefits for both patients and healthcare providers. Accessible from any validated device through the cloud, it offers rapid performance and easy deployment without the exchange of PHI, ensuring complete security. Fully connected to PACS, RIS, EMR, and dictation software, Arterys enhances your workflow without disruption. Its rapid deployment capabilities require minimal on-premise infrastructure, and it is commercially available in more than 100 countries. The platform's elastic cloud GPU architecture significantly boosts the performance of various tasks, such as rendering complex 3D files, handling large multi-dimensional datasets, and executing multiple AI applications simultaneously in real time. Additionally, features like pre-fetching and image caching contribute to quicker loading times and more efficient analysis, making it an indispensable tool in modern healthcare. This comprehensive approach positions Arterys as a leader in transforming medical imaging through artificial intelligence.

Pulse is a cloud-based solution designed for echocardiography labs aiming to enhance efficiency and patient outcomes. This platform facilitates reporting, storage, and analysis of echocardiograms, ensuring that you can access patient information whenever and wherever it's needed. Physicians benefit from the ability to review studies and finalize reports from virtually any location, making it an essential tool for contemporary echocardiography practices. With a user-friendly and robust reporting interface conveniently located alongside images and measurements, Pulse empowers users to navigate their tasks seamlessly. Its AI-driven features allow for fully automated measurements of GLS, LVEF, LVEDV, and LVESV, eliminating the need for manual input. Furthermore, the platform minimizes security risks while maximizing the advantages associated with cloud-native technology. Reports can be sent directly to your electronic health record (EHR) via HL7, effectively streamlining clinical workflows. You can easily store new studies right from the cart or retrieve existing studies from an external PACS. Moreover, integrated support for DICOM-TLS simplifies the management of secure data access, sparing users from the complexities of VPN setups. Overall, Pulse is revolutionizing the way echocardiography labs operate by combining technology with clinical expertise.

IntelliSpace Portal 9.0 is an innovative visualization platform encompassing over 70 clinical applications, providing a cohesive solution that enhances speed and efficiency while boosting diagnostic confidence, particularly in the analysis and monitoring of complex cases. As the global population ages, the prevalence of neurodegenerative diseases continues to escalate, necessitating long-term monitoring for patients with neurological disorders, which can often exhibit subtle brain changes that are difficult to identify. To address these challenges, IntelliSpace Portal 9.0 introduces several new and improved neuro applications, including NeuroQuant®¹, LoBi, and CT Brain Perfusion, all designed for swift, objective, and consistent image assessment. Additionally, with a growing focus on pulmonary health, this platform equips you with a comprehensive suite of tools to seamlessly manage pulmonary disease from initial detection through to ongoing follow-up, ultimately aiming to improve patient outcomes. This integration of neuro and pulmonary features positions IntelliSpace Portal 9.0 as a vital resource in modern medical imaging and diagnostics.

Ambra Health offers an advanced cloud-based platform designed for the management of medical data and images, catering to hospitals, radiology practices, medical groups, and contract research organizations. This platform is scalable, user-friendly, and highly compatible with other systems, enabling healthcare providers to enhance collaboration through seamless image sharing with patients and various departments. With Ambra’s secure storage solution, users can consolidate all imaging data into a unified repository, accommodating a wide range of medical imaging file formats such as TFF, JPEG, and DOC among others. Key functionalities of the platform include an EMR HL7 Bridge, integration with PACS, a Cloud VNA, EMR/EHR integration, telestroke services, and an informatics-first migration approach. Ambra Health not only streamlines the management of medical images but also ensures compliance with industry standards, thereby promoting better patient care and operational efficiency. These features make it a crucial tool for organizations aiming to optimize their imaging workflows in a rapidly evolving healthcare landscape.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

Quantib Brain is a radiology software solution that has received FDA clearance and CE marking, specifically designed for the segmentation of brain scans. Collaboratively developed with GE Healthcare, it operates as a plug-in for the Advantage Workstation (Server), delivering automated quantification of brain structures in a user-friendly software setting. This innovative tool allows for the longitudinal analysis of brain volume measurements, encompassing white matter, grey matter, intracranial volume, and cerebrospinal fluid, which aids in monitoring the progression of atrophy. Furthermore, it includes functionality for the segmentation and tracking of white matter hyperintensities. Quantib Brain offers a detailed summary of volumes for grey matter, white matter, ICV, CSF, and total brain volume, all presented in a clear results table. Users can also benefit from self-selected cross-sections, which can be easily exported into a detailed report, ensuring all examination findings are readily shareable for collaborative review. This capability enhances the overall efficiency of diagnosis and patient management in clinical settings.

The SenseCare Smart Health Platform, created by SenseTime, represents a powerful diagnostic and treatment support tool that integrates cutting-edge AI algorithms with sophisticated image post-processing capabilities. Leveraging extensive medical big data, this platform is designed to offer intelligent solutions for multiple clinical departments, enhancing the entire cycle of diagnosis, treatment, and recovery while increasing the precision and effectiveness of doctors' planning and decision-making processes. Furthermore, SenseCare allows for effortless integration with existing CT, MRI, and X-ray devices, as well as PACS, without disrupting the established workflows within healthcare facilities. Users across the hospital can conveniently log into the platform and conduct analyses through web browsers on a range of portable devices, eliminating the need for additional plug-ins. The system also supports a variety of automated 3D post-processing techniques, including MPR, CPR, and VR, thereby streamlining the workflows associated with diagnosis, treatment, and rehabilitation. By facilitating these processes, SenseCare not only enhances operational efficiency but also fosters improved patient outcomes through more effective healthcare delivery.

Three Palm Software has developed a breast imaging workstation named WorkstationOne, which features a unique approach to enterprise integration and interpretation workflow. Recognizing the challenges faced by radiologists transitioning to digital mammography, the company emphasizes the importance of enabling efficient reviews of digital mammograms that match the speed of traditional film readings on motorized lightboxes. The workstation boasts a sleek and user-friendly interface tailored to accommodate the rigorous demands of radiologists. It employs advanced viewing strategies, such as Tabár’s systematic viewing mask techniques, to enhance the detection of subtle radiographic abnormalities. Users can navigate full-resolution images seamlessly with a mouse wheel, allowing for visual tracking of pixels that have already been examined, thus eliminating the need for manual panning and zooming to ensure all pixels are viewed in their highest clarity. This innovation not only streamlines the workflow but also enhances diagnostic accuracy for healthcare professionals.